1. Home
  2. POWL vs KYMR Comparison

POWL vs KYMR Comparison

Compare POWL & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

HOLD

Current Price

$243.62

Market Cap

8.5B

Sector

Energy

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$111.31

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWL
KYMR
Founded
1947
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
POWL
KYMR
Price
$243.62
$111.31
Analyst Decision
Buy
Strong Buy
Analyst Count
4
26
Target Price
$184.25
$107.72
AVG Volume (30 Days)
691.9K
1.2M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
0.14%
N/A
EPS Growth
20.91
N/A
EPS
2.39
N/A
Revenue
$448,716,000.00
$39,211,000.00
Revenue This Year
$11.20
$10.61
Revenue Next Year
$9.12
$8.17
P/E Ratio
$100.70
N/A
Revenue Growth
13.34
N/A
52 Week Low
$178.05
$36.88
52 Week High
$612.50
$130.05

Technical Indicators

Market Signals
Indicator
POWL
KYMR
Relative Strength Index (RSI) 43.77 52.08
Support Level $222.93 $76.40
Resistance Level $248.33 $120.90
Average True Range (ATR) 11.06 5.31
MACD 1.31 -1.75
Stochastic Oscillator 46.72 8.67

Price Performance

Historical Comparison
POWL
KYMR

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: